Possibility of the Prediction of Metastasis Using Molecular Biological Examination of Biopsy Specimens in Patients with Gastric Cancer -Clinical Study of CD44 Variant mRNA Expression in Gastric Cancer-

Keigo Yamamichi, Yoshihiko Uehara*, Tsunehide Osawa, Tokio Okusa, Kanji Tanaka, Yasushi Nakane, Koshiro Hioki, Naomi Kitamura¹⁾

Second Department of Surgery and *Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University
Department of Life Science, Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology¹⁾

CD44 is a cell surface adhesion molecule involved in cell-cell and cell-matrix in teractions. CD44 exists in a standard form and in multiple isoforms, each generated by alternative splicing of up to 10 variant exons (termed v1-v10) encoding parts of the extracellular domain. Expressions of CD44 and its variants are associated with cancer progression and metastasis. We examined the expression of CD44 containing a segment encoded by variant exon 6 (CD44v6) mRNA in 73 cases of gastric cancer using molecular biological examination of surgical specimens. The level of CD44v6 mRNA expression was significantly higher in patients with lymph node metastasis and liver metastasis. In 48 curatively resected patients, the level of CD44v6 mRNA expression significantly correlated with recurrence. Furthermore, there was a significant survival advantage in patients iwth a low level of CD44v6 mRNA expression as compared to those with high expression. We also examined the level of CD44v6 mRNA expression in endoscopic biopsy specimens from 25 cases of gastric cancer. The expression of CD44v6 mRNA in biopsy specimens was similar to that in surgical specimens from the same patient. These results suggest that the level of CD446 v mRNA expression is a potential prognostic indicator and may be useful as a preoperative predictor of distant metastasis and recurrence in patients with gastric cancer.

Key words
CD44, gastric cancer, RT-PCR

Reprint requests
Keigo Yamamichi Second Department of Surgery, Kansai Medical University
10-15 Fumizonocho, Moriguchi, 570 JAPAN

Accepted
December 11, 1996

To read the PDF file you will need Abobe Reader installed on your computer.